Skip to main content

Table 3 Logistic regression models in the total ICU population excluding patients admitted after elective cardiac surgery

From: Impact of chloride and strong ion difference on ICU and hospital mortality in a mixed intensive care population

 

Outcome: 30-day mortalitya (n = 6480)

Outcome: hospital mortalityb (n = 5184)

n

% outcome (%)

Odds ratio (95 % CI) versus normochloremia

p value

n

% outcome (%)

Odds ratio (95 % CI) versus normochloremia

p value

Chloride category

Normochloremia

3382

10.2

  

2707

24.3

  

Hypochloremia

434

16.4

1.02 (0.71–1.48)

0.91

329

43.8

1.55 (1.13–2.13)

0.007

Moderate hyperchloremia

1456

8.5

1.16 (0.88–1.51)

0.30

1188

18.4

0.96 (0.77–1.20)

0.72

Severe hyperchloremia

1208

14.6

1.81 (1.32–2.50)

<0.001

960

29.0

1.49 (1.14–1.96)

0.003

 

n

% outcome (%)

Odds ratio (95 % CI) versus intermediate SIDa

p value

n

% outcome (%)

Odds ratio (95 % CI) versus intermediate SIDa

p value

SIDa category

Intermediate SIDa

2982

9.6

  

2382

20.5

  

Low SIDa

1598

9.4

0.89 (0.68–1.16)

0.40

1260

21.5

0.94 (0.70–1.15)

0.60

High SIDa

1900

14.6

1.05 (0.83–1.32)

0.71

1542

34.9

1.35 (1.11–1.65)

0.002

 

Area under ROC 86.7 %

  

Area under ROC 83.5 %

Maximal VIF 2.26

 

Maximal VIF 2.39

Tolerance 0.68

 

Tolerance 0.68

  1. SIDa apparent strong ion difference (excl. lactate), ROC receiver under operating characteristics curve, VIF variance inflation factor
  2. aConfounders adjusted for in the model: sodium (high vs. normal*, low vs. normal*), SAPS-3, admission reason, RIFLEcrea*, RIFLEurine, lactate, heart failure*, COPD*, pCO2* (low, normal, high), albumin, SIG, potentiometry type* (*p > 0.05)
  3. bConfounders adjusted for in the model: sodium (high vs. normal*, low vs. normal*), SAPS-3, admission reason, RIFLEcrea, RIFLEurine, lactate, heart failure, COPD, pCO2* (low, normal, high), albumin, SIG*, potentiometry type (*p > 0.05)